VersaBank
VBNKNASDAQFinancial Services● Active
$19.65
+$0.42(+2.18%)
Market Cap$632645446
P/E Ratio—
52W High$20.77
52W Low$10.1
VersaBank（VBNK）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · VBNK · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-10 | 2024-10 | 2023-10 | 2022-10 | 2021-10 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.12B | $0.11B | $0.24B | $0.13B | $0.09B |
| Cost of Revenue | $0.00B | $0.00B | $0.13B | $0.05B | $0.03B |
| Gross Profit | $0.12B | $0.11B | $0.11B | $0.08B | $0.07B |
| Gross Margin %(computed) | 100.00% | 100.00% | 45.40% | 61.82% | 69.49% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.03B | $0.05B | $0.05B | $0.05B | $0.03B |
| Total Operating Expenses | $0.08B | $0.06B | $0.05B | $0.05B | $0.04B |
| Operating Income | $0.04B | $0.05B | $0.06B | $0.03B | $0.03B |
| Operating Margin %(computed) | 34.51% | 49.08% | 24.23% | 24.56% | 32.52% |
| Interest Income | $0.30B | $0.29B | $0.23B | $0.13B | $0.09B |
| Interest Expense | $0.18B | $0.18B | $0.13B | $0.05B | $0.03B |
| Income Before Tax | $0.04B | $0.05B | $0.06B | $0.03B | $0.03B |
| Income Tax Expense | $0.01B | $0.02B | $0.02B | $0.01B | $0.01B |
| Net Income | $0.03B | $0.04B | $0.04B | $0.02B | $0.02B |
| Net Margin %(computed) | 23.67% | 35.61% | 17.72% | 17.09% | 23.64% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.90 | $1.49 | $1.53 | $0.79 | $0.96 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.02B |
| EBITDA | $0.04B | $0.06B | $0.06B | $0.03B | $0.03B |
| EBITDA Margin %(computed) | 37.09% | 51.44% | 24.98% | 26.02% | 34.34% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CAD · B
深入了解VersaBank
关于VersaBank（VBNK）损益表
VersaBank（VBNK）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，VBNK实现营收$0.12B，毛利润$0.12B（毛利率100.00%），净利润$0.03B（净利率23.67%）。
常见问题
VBNK · 4 问VersaBank（VBNK）2025财年营收为$0.12B，同比up7.7%。
VBNK revenueVBNK salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09